Signifier Medical Technologies, a medical technology company, has named Philip Hess as its new chief operating officer, it was reported on Tuesday.
In the new role, Hess will be responsible for increasing Signifier Medical Technologies' US infrastructure in preparation for the commercialisation of the company's products. He will also head the establishment of new research and development function to identify and leverage innovative science to create new product opportunities for the company.
Hess has served as president & CEO of Bose Corporation, where he worked for 24 years across multiple leadership and operational roles.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business